GoHealth shares plunged 53.7% in pre-open trading after the company late Sunday filed voluntary Chapter 11 petitions with the United States Bankruptcy Court for the District of Delaware and initiated a prepackaged restructuring aimed at moving ownership to a consortium of its lenders.
Under the terms of the announced plan, existing common equity holders face severe dilution or near-elimination of their holdings. The restructuring is structured to transfer control to the company’s creditors while reinstating preferred equity and paying trade creditors in full, effectively prioritizing creditor recovery over common stock value.
The bankruptcy filing follows a pronounced deterioration in the company’s operating and balance-sheet metrics. GoHealth reported first-quarter 2026 net revenues of $11.9 million, a steep drop from $221 million in the same quarter a year earlier. At the same time, the company carries more than $700 million of term loan debt at an effective interest rate near 14.7% and had already disclosed substantial doubt about its ability to continue as a going concern in its most recent regulatory filings.
Management also indicated it expects its Class A common stock to be delisted from the Nasdaq Global Market, with shares potentially moving to the over-the-counter market. Such a migration typically accelerates institutional selling and reduces the liquidity and visibility of a company’s equity.
The broader market environment offered no shelter for distressed names on the trading day in question. The S&P 500 declined 2.6%, the Nasdaq fell 4.2%, and the Dow Jones Industrial Average dropped 1.4%, contributing to a risk-off tone that amplified selling pressure across speculative and financially stressed equities. The steep pre-market fall pushed GOCO shares down to $0.31 as market participants rapidly repriced the stock toward its potential residual recovery value under the restructuring.
Peers in the Medicare insurance marketplace did not report material news on the same day. Companies such as eHealth and SelectQuote did not announce company-specific developments, leaving GoHealth’s collapse fully attributable to its own corporate actions and financial disclosures.
The convergence of a bankruptcy filing, a likely Nasdaq delisting, and a negative market backdrop created a concentrated catalyst for the pre-market selloff. With ownership slated to move to lenders and common equity facing near-total impairment, the sharp move in the stock reflected immediate market revaluation of shareholder recovery prospects under the restructuring plan.
Clear summary
GoHealth filed voluntary Chapter 11 petitions and launched a prepackaged restructuring to transfer control to lenders, prompting a 53.7% pre-market drop in its shares. The plan threatens severe dilution or elimination of common equity, follows a collapse in Q1 2026 revenue to $11.9 million from $221 million a year earlier, and occurs amid more than $700 million of term loan debt at an effective interest rate near 14.7%. Management expects potential delisting from the Nasdaq Global Market.